ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Entero Therapeutics Inc

Entero Therapeutics Inc (ENTO)

0,6148
-0,0218
( -3,42% )
Mis à jour : 17:54:38

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
0,6148
Prix Achat
0,615
Prix Vente
0,63
Volume échangé
23 619
0,61 Fourchette du Jour 0,652
0,185 Plage de 52 semaines 3,16
Clôture Veille
0,6366
Ouverture
0,64
Dernière Transaction
1
@
0.6224
Dernière heure de transaction
17:52:55
Volume moyen (3 m)
417 007
Volume financier
US$ 14 551
VWAP
0,616069

ENTO Dernières nouvelles

Entero Therapeutics Signs Letter of Intent to License and Commercialize Remote Patient and Machine Vision Clinical Trial Management Platform from Data Vault Holdings

BOCA RATON, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q

BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program

BOCA RATON, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Intestinal Damage in Celiac Disease

New VCIEL scale provides a more sensitive and quantitative metric of small intestinal health for monitoring Celiac Disease severity and treatment efficacy Special editorial highlights the...

Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention

BOCA RATON, Fla., May 22, 2024 (GLOBE NEWSWIRE) --  Entero Therapeutics, Inc. (formerly First Wave BioPharma, Inc.) (Nasdaq: ENTO) (“Entero” or the “Company”), a late clinical-stage...

Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference

BOCA RATON, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing in...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.0392-5.993883792050.6540.7161990.6310390.66925001CS
40.136928.64616028460.47790.86550.4472485860.64895279CS
120.3198108.4067796610.2950.86550.25014170070.54455823CS
26-2.3452-79.22972972972.963.160.1854726570.4721061CS
52-2.3452-79.22972972972.963.160.1854726570.4721061CS
156-2.3452-79.22972972972.963.160.1854726570.4721061CS
260-2.3452-79.22972972972.963.160.1854726570.4721061CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BTCTBTC Digital Ltd
US$ 11,01
(336,90%)
81,37M
PAMTPAMT Corporation
 20,70
(64,16%)
18,27k
BTCSBTCS Inc
US$ 2,89
(53,72%)
28,25M
LGMKLogicMark Inc
US$ 0,2018
(51,73%)
485,49M
GNPXGenprex Inc
US$ 1,977
(47,54%)
13,58M
STIMNeuronetics Inc
US$ 0,6206
(-43,58%)
5,2M
NGNENeurogene Inc
US$ 40,38
(-43,55%)
597,4k
PGYPagaya Technologies Ltd
US$ 11,07
(-34,46%)
8,14M
RAILFreightCar America Inc
US$ 10,35
(-34,12%)
1,6M
RMTIRockwell Medical Inc
US$ 3,11
(-33,12%)
3,82M
CEROCERo Therapeutics Holdings Inc
US$ 0,2625
(33,93%)
572,92M
LGMKLogicMark Inc
US$ 0,2018
(51,73%)
485,49M
LIFWMSP Recovery Inc
US$ 0,1479
(16,73%)
149,24M
NVDANVIDIA Corporation
US$ 149,1699
(2,69%)
100,68M
ELABElevai Labs Inc
US$ 0,0185
(-4,15%)
92,99M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock